
HQ - Waltham, MA
Summary
Affinia Therapeutics, an innovative gene therapy company with a pipeline of first-in-class and/or best-in-class adeno-associated virus (AAV) gene therapies for devastating cardiovascular and neurological diseases.
Deals Overview
All rights reserved. Copyright © 2025 Datasite
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
Senior Management
Rick Modi
CEO
Petra Kaufmann
Chief Medical Officer
Charles Albright
CSO